Evidence map›Paper›PMID 28777263›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2017

Stepped-Wedge Cluster Randomized Controlled Trial to Promote Option B+ Retention in Central Mozambique.

James T Pfeiffer, Manuel Napúa, Bradley H Wagenaar, Falume Chale, Roxanne Hoek, Mark Micek, João Manuel, Cathy Michel, Jessica Greenberg Cowan, James F Cowan and 4 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

James T Pfeiffer*Department of Global Health, University of Washington, Seattle, WA; †Health Alliance International, Seattle, WA; ‡Department of Anthropology, University of Washington, Seattle, WA; §Ministry of Health, Beira Operational Research Center, Beira, Mozambique; ‖Health Alliance International, Beira, Mozambique; ¶Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI; #Department of Family Medicine, University of Washington, Seattle, WA; and **Department of Family and Child Nursing, School of Nursing, University of Washington, Seattle, WA.
Manuel Napúa
Bradley H Wagenaar
Falume Chale
Roxanne Hoek
Mark Micek
João Manuel
Cathy Michel
Jessica Greenberg Cowan
James F Cowan
Sarah Gimbel
Kenneth Sherr
Stephen Gloyd
Rachel R Chapman

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Early ART initiation among HIV-positive pregnant women in central MozambiqueR01HD074557 · NICHD · UNIVERSITY OF WASHINGTON · PI CHAPMAN, RACHEL REBEKAH, PFEIFFER, JAMES T. · 2012 to 2014
$1.5M
NIAID NIH HHS P30 AI027757NICHD NIH HHS R01 HD074557
6 · The paper itself

Abstract

backgroundThis randomized trial studied performance of Option B+ in Mozambique and evaluated an enhanced retention package in public clinics.

settingThe study was conducted at 6 clinics in Manica and Sofala Provinces in central Mozambique.

methodsSeven hundred sixty-one pregnant women tested HIV+, immediately initiated antiretroviral (ARV) therapy, and were followed to track retention at 6 clinics from May 2014 to May 2015. Clinics were randomly allocated within a stepped-wedge fashion to intervention and control periods. The intervention included (1) workflow modifications and (2) active patient tracking. Retention was defined as percentage of patients returning for 30-, 60-, and 90-day medication refills within 25-35 days of previous refills.

resultsDuring control periods, 52.3% of women returned for 30-day refills vs. 70.8% in intervention periods [odds ratio (OR): 1.80; 95% confidence interval (CI): 1.05 to 3.08]. At 60 days, 46.1% control vs. 57.9% intervention were retained (OR: 1.82; CI: 1.06 to 3.11), and at 90 days, 38.3% control vs. 41.0% intervention (OR: 1.04; CI: 0.60 to 1.82). In prespecified subanalyses, birth before pickups was strongly associated with failure-women giving birth before ARV pickup were 33.3 times (CI: 4.4 to 250.3), 7.5 times (CI: 3.6 to 15.9), and 3.7 times (CI: 2.2 to 6.0) as likely to not return for ARV pickups at 30, 60, and 90 days, respectively.

conclusionsThe intervention was effective at 30 and 60 days, but not at 90 days. Combined 90-day retention (40%) and adherence (22.5%) were low. Efforts to improve retention are particularly important for women giving birth before ARV refills.

Indexed as

Drug MonitoringAdultAnti-HIV AgentsCD4 Lymphocyte CountDelivery of Health CareFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalMiddle AgedMozambiquePatient Acceptance of Health CarePregnancyPregnancy Complications, InfectiousYoung AdultAnti-HIV Agents

Identifiers

PMID28777263
PMCPMC7055502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.